Femasys Stock Investor Sentiment

FEMY Stock  USD 1.04  0.02  1.89%   
Slightly above 61% of Femasys' investor base is looking to short. The analysis of overall sentiment of trading Femasys stock suggests that many investors are alarmed at this time. Femasys' investing sentiment can be driven by a variety of factors including economic data, Femasys' earnings reports, geopolitical events, and overall market trends.
  

Femasys Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Femasys can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
2 days ago at finance.yahoo.com         
Femasys Announces Peer-Reviewed Publication of Positive Data from Prospective, Multicenter Pivotal T...
Yahoo News
2 days ago at gurufocus.com         
Femasys Announces Peer-Reviewed Publication of Positive Data fro
Gurufocus Stories at Macroaxis
over a week ago at news.google.com         
Femasys price target lowered to 8 from 10 at Chardan - MSN
Google News at Macroaxis
over a week ago at thelincolnianonline.com         
Aljian Capital Management LLC Makes New 27,000 Investment in Femasys Inc.
news
over a week ago at thelincolnianonline.com         
FY2024 Earnings Forecast for Femasys Issued By HC Wainwright
news
over two weeks ago at thelincolnianonline.com         
Femasys Given Buy Rating at HC Wainwright
news
over two weeks ago at globenewswire.com         
Femasys Announces Financial Results for Quarter Ended September 30, 2024, and Provides Corporate Upd...
Macroaxis News: globenewswire.com
over two weeks ago at seekingalpha.com         
Femasys GAAP EPS of -0.24, revenue of 554.91M
seekingalpha News
over two weeks ago at zacks.com         
Zealand Pharma AS Reports Q3 Loss, Lags Revenue Estimates
zacks News
over two weeks ago at finance.yahoo.com         
Femasys to Exhibit at the Annual AAGL 2024 Global Conference
Yahoo News
over two weeks ago at zacks.com         
Arcutis Biotherapeutics, Inc. Reports Q3 Loss, Tops Revenue Estimates
zacks News
over three weeks ago at news.google.com         
FEMY - Femasys Inc. Latest Stock News Market Updates - StockTitan
Google News at Macroaxis
over three weeks ago at globenewswire.com         
Femasys Announces Issued U.S. Patent Covering FemBlocDevice for Female Permanent Birth Control
Macroaxis News: globenewswire.com
over three weeks ago at simplywall.st         
Femasys Has Debt But No Earnings Should You Worry?
Simply Wall St News at Macroaxis
over a month ago at finance.yahoo.com         
Femasys to Exhibit at ASRM 2024 and Participate in the Congress KEEPR Education Program
Yahoo News
Far too much social signal, news, headlines, and media speculation about Femasys that are available to investors today. That information is available publicly through Femasys media outlets and privately through word of mouth or via Femasys internal channels. However, regardless of the origin, that massive amount of Femasys data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Femasys news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Femasys relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Femasys' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Femasys alpha.

Femasys Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Femasys to Exhibit at The Canadian Fertility and Andrology Societys 70th Annual Meeting
09/05/2024
2
Acquisition by Larsen Charles of 8500 shares of Femasys subject to Rule 16b-3
09/06/2024
3
Femasys Inc. Receives U.S. FDA Clearance to Market FemChec, an Innovative Diagnostic Solution for Fallopian Tube Check
09/09/2024
4
Femasys Secures Strategic Distribution Partnerships for Commercialization of FemaSeed for over 1.3M in Spanish Market
09/11/2024
5
Acquisition by Uzialko Edward R of 8500 shares of Femasys at 0.57 subject to Rule 16b-3
09/25/2024
6
Femasys to Exhibit at ASRM 2024 and Participate in the Congress KEEPR Education Program
10/10/2024
7
Femasys Announces Issued U.S. Patent Covering FemBlocDevice for Female Permanent Birth Control
11/01/2024
8
Femasys to Exhibit at the Annual AAGL 2024 Global Conference
11/07/2024
9
Femasys Announces Financial Results for Quarter Ended September 30, 2024, and Provides Corporate Update
11/12/2024
10
Aljian Capital Management LLC Makes New 27,000 Investment in Femasys Inc.
11/19/2024
11
Femasys Announces Peer-Reviewed Publication of Positive Data from Prospective, Multicenter Pivotal Trial of FemaSeed Infertility Treatment
11/26/2024

Additional Tools for Femasys Stock Analysis

When running Femasys' price analysis, check to measure Femasys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Femasys is operating at the current time. Most of Femasys' value examination focuses on studying past and present price action to predict the probability of Femasys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Femasys' price. Additionally, you may evaluate how the addition of Femasys to your portfolios can decrease your overall portfolio volatility.